Christopher Scott

Christopher Scott, Ph.D., M.A.

Picture

Christopher Scott, Ph.D., M.A.

Dalton Tomlin Professor of Medical Ethics and Health Policy

Email

christopher.scott@bcm.edu

Positions

Dalton Tomlin Professor of Medical Ethics and Health Policy: Baylor College of Medicine
Houston, Texas

Member: Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine

Addresses

Baylor College of Medicine (Office)
: One Baylor Plaza
Room: BCMD-310DL
Houston, TX 77030
United States
Phone: (415) 533-1954
christopher.scott@bcm.edu

Education

BA from University of Colorado: 05/1978 - Boulder, Colorado United States

MA from Stanford University: 05/2005 - Stanford, California United States; Ethics and Policy

PhD from University of British Columbia: 09/2013 - Vancouver, Canada; Policy and Ethics

Professional Interests

Empirical ethics
First-in-human clinical trials
Genomics and gene editing
Stem cells and regenerative medicine
Ethics of entrepreneurship
Medical tourism
Public Outreach

Professional Statement

Dr. Scott is the Dalton Tomlin Chair in Medical Ethics and Health Policy. He received his BA in biology and biopsychology from the University of Colorado (Boulder), his MLA in ethics and policy from Stanford University, and his Ph.D. from the University of British Columbia, Vancouver. His research uses qualitative and quantitative approaches to study the ethical, legal, social, and policy implications of emerging biotechnologies and clinical medicine. Dr. Scott is an emeritus faculty and senior research scholar at the Stanford University Center for Bioethics and past Director of the Stanford Program on Stem Cells in Society.

Websites

ResearchGate

Follow me on ResearchGate. Full-text publications available under Contributions tab.

Twitter

Personal and Professional Twitter account

Facebook

Personal Facebook page

Selected Publications

Barlevy D and Scott CT "How ethics can better anticipate the consequences of Emerging biotechnologies." Am J Bioeth. 2022;22(1):46-48.
Farrell RM, Malek JI, Scott CT "Beyond babies: Implications of human genome editing for women, children, and families." Account Res. 2022 Feb;29(2):67-76. Pubmed PMID: 33667136
Nelson JP, Selin CL, Scott CT "Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse." J Responsible Innov. 2021;8(3):382-420. Pubmed PMID: 35281674
Sharma A, Zuk, P and Scott CT "Scientific and Ethical Uncertainties in Brain Organoid Research." Am J Bioeth. 2021 Jan;21(1):48-51. Pubmed PMID: 33373560

Farrell RM, Michie M, Scott CT "Prioritizing Women's Health in Germline Editing Research." AMA J Ethics. 2019 Dec 1;21(12):E1071-1078. Pubmed PMID: 31876472
Scott CT and Selin C "What to Expect When Expecting CRISPR Baby Number Four." Am J Bioeth. 2019 Mar;19(3):7-9. Pubmed PMID: 30896351
Majumder M and Scott CT "Off-Target Effects of a Defense of Denial." Am J Bioeth. 2018 Sep;18(9):22-24. Pubmed PMID: 30265597
Senatore V, Scott CT, Sebastiano V "Patenting Parthenotes in the US and Europe." Nat Biotechnol. 2015 Dec 9;33(12):1232-1243. Pubmed PMID: 26650007
Senatore V and Scott CT "Europe's Landmark Decisions on Stem Cell Patents: Hope or Mere Illusion." AIPLA Quarterly. 2015 Jun;43(3):241-288.
Scott CT "Backwards by Design: Building ELSI into a Science Curriculum." Hastings Cent. Rep.. 2015 May;45(3):26-32. Pubmed PMID: 25944206
Sharma A and Scott CT "The Ethics of Publishing Human Germline Research." Nat Biotechnol. 2015 Jun;33(6):590-2. Pubmed PMID: 26252145
Jacob KJ, Longstaff H, Scott CT, Illes J "Focus on the People and the Science Will Follow." Stem Cell Rev. 2015 Aug 11;4:533-9. Pubmed PMID: 26022505